Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helena Canhao

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Frontiers in Medicine|May 29, 2019
Editorial: Nutrition and Metabolism in Rheumatic DiseasesHelena Canhao, Kayo Masuko, Hiroshi Nakamura
Frontiers in Medicine|October 23, 2018
Editorial: Active Aging and Disease ManagementHelena Canhao, Jaime C Branco, Giuseppe Liotta
Clinical Rheumatology|August 9, 2007
Assessment of laboratory measurements and -308 TNFalpha gene promoter polymorphisms in normal bone mineral densityHelena Canhao, Joao Eurico Fonseca, Joana Caetano-Lopes, et al.
The Journal of Rheumatology|April 5, 2011
Lymphotoxin-α 252 A>G polymorphism: a link between disease susceptibility and dyslipidemia in rheumatoid arthritis?Maria J Santos, Diana Fernandes, Joana Caetano-Lopes, et al.
Frontiers in Medicine|May 22, 2018
Active Ageing in Europe: Adding Healthy Life to YearsGiuseppe Liotta, Helena Canhao, Fabian Cenko, et al.
Frontiers in Public Health|August 29, 2022
Treatment-resistant depression and major depression with suicide risk-The cost of illness and burden of diseaseRute Dinis Sousa, Miguel Gouveia, Catarina Nunes da Silva, et al.
Plos One|August 27, 2013
Automatic prediction of rheumatoid arthritis disease activity from the electronic medical recordsChen Lin, Elizabeth W Karlson, Helena Canhao, et al.
Annals of the Rheumatic Diseases|June 17, 2016
Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registersLouise K Mercer, Johan Askling, Pauline Raaschou, et al.
Annals of the Rheumatic Diseases|September 17, 2015
Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative studyCem Gabay, Myriam Riek, Merete Lund Hetland, et al.
The Journal of Rheumatology|January 17, 2017
Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA CollaborationKaterina Chatzidionysiou, Elisabeth Lie, Galina Lukina, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Frontiers in Medicine|May 29, 2019
Editorial: Nutrition and Metabolism in Rheumatic DiseasesHelena Canhao, Kayo Masuko, Hiroshi Nakamura
Frontiers in Medicine|October 23, 2018
Editorial: Active Aging and Disease ManagementHelena Canhao, Jaime C Branco, Giuseppe Liotta
Clinical Rheumatology|August 9, 2007
Assessment of laboratory measurements and -308 TNFalpha gene promoter polymorphisms in normal bone mineral densityHelena Canhao, Joao Eurico Fonseca, Joana Caetano-Lopes, et al.
The Journal of Rheumatology|April 5, 2011
Lymphotoxin-α 252 A>G polymorphism: a link between disease susceptibility and dyslipidemia in rheumatoid arthritis?Maria J Santos, Diana Fernandes, Joana Caetano-Lopes, et al.
Frontiers in Medicine|May 22, 2018
Active Ageing in Europe: Adding Healthy Life to YearsGiuseppe Liotta, Helena Canhao, Fabian Cenko, et al.
Frontiers in Public Health|August 29, 2022
Treatment-resistant depression and major depression with suicide risk-The cost of illness and burden of diseaseRute Dinis Sousa, Miguel Gouveia, Catarina Nunes da Silva, et al.
Plos One|August 27, 2013
Automatic prediction of rheumatoid arthritis disease activity from the electronic medical recordsChen Lin, Elizabeth W Karlson, Helena Canhao, et al.
Annals of the Rheumatic Diseases|June 17, 2016
Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registersLouise K Mercer, Johan Askling, Pauline Raaschou, et al.
Annals of the Rheumatic Diseases|September 17, 2015
Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative studyCem Gabay, Myriam Riek, Merete Lund Hetland, et al.
The Journal of Rheumatology|January 17, 2017
Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA CollaborationKaterina Chatzidionysiou, Elisabeth Lie, Galina Lukina, et al.
Pageof 2